NO20040905L - Peptidaktige forbindelser som selektivt binder til P-selektin, farmasoytiske preparater som inneholder peptidforbindelsene og nukleinsyrer som koder for dem. - Google Patents

Peptidaktige forbindelser som selektivt binder til P-selektin, farmasoytiske preparater som inneholder peptidforbindelsene og nukleinsyrer som koder for dem.

Info

Publication number
NO20040905L
NO20040905L NO20040905A NO20040905A NO20040905L NO 20040905 L NO20040905 L NO 20040905L NO 20040905 A NO20040905 A NO 20040905A NO 20040905 A NO20040905 A NO 20040905A NO 20040905 L NO20040905 L NO 20040905L
Authority
NO
Norway
Prior art keywords
compounds
peptide
selectin
nucleic acids
acids encoding
Prior art date
Application number
NO20040905A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Jacobus Maria Molenaar
Johan Kuiper
Theodorus Josephus Come Berkel
Erik Anna Biessen
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of NO20040905L publication Critical patent/NO20040905L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20040905A 2001-09-03 2004-03-02 Peptidaktige forbindelser som selektivt binder til P-selektin, farmasoytiske preparater som inneholder peptidforbindelsene og nukleinsyrer som koder for dem. NO20040905L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203314A EP1288222A1 (en) 2001-09-03 2001-09-03 Peptidic compounds selectively binding to P-selectin
PCT/NL2002/000566 WO2003020753A1 (en) 2001-09-03 2002-08-28 Peptidic compounds selectively binding to p-selectin

Publications (1)

Publication Number Publication Date
NO20040905L true NO20040905L (no) 2004-05-26

Family

ID=8180873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040905A NO20040905L (no) 2001-09-03 2004-03-02 Peptidaktige forbindelser som selektivt binder til P-selektin, farmasoytiske preparater som inneholder peptidforbindelsene og nukleinsyrer som koder for dem.

Country Status (16)

Country Link
US (1) US7531516B2 (enExample)
EP (2) EP1288222A1 (enExample)
JP (1) JP4227520B2 (enExample)
CN (1) CN100413883C (enExample)
AT (1) ATE446311T1 (enExample)
BR (1) BR0212219A (enExample)
CA (1) CA2459230C (enExample)
DE (1) DE60234108D1 (enExample)
ES (1) ES2337663T3 (enExample)
HR (1) HRP20040127A2 (enExample)
HU (1) HUP0401728A2 (enExample)
MX (1) MXPA04002055A (enExample)
NO (1) NO20040905L (enExample)
PL (1) PL369030A1 (enExample)
WO (1) WO2003020753A1 (enExample)
ZA (1) ZA200400956B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60318585T2 (de) * 2002-08-09 2009-01-08 Astellas Pharma Europe B.V. Verbindungen die p-selectin binden
ES2334220T3 (es) 2002-10-11 2010-03-08 Astellas Pharma Europe B.V. Compuestos basados en glucosa con afinidad por la p-selectiva.
EP1481683A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. P-selectin targeting ligand and compositions thereof
US9107963B2 (en) * 2012-04-13 2015-08-18 Case Western Reserve University Heteromultivalent nanoparticle compositions
US9833518B2 (en) 2012-04-13 2017-12-05 Case Western Reserve University Heteromultivalent particle compositions
US10279347B2 (en) * 2014-04-08 2019-05-07 Dna Medicine Institute, Inc. Fluidics module
US11879012B2 (en) 2018-03-02 2024-01-23 Peter GILLIES Method of modulating cell proliferation
CN111671905B (zh) * 2020-06-23 2022-05-27 中国医学科学院医学实验动物研究所 P-选择蛋白糖蛋白配体-1作为靶点在制备预防和/或治疗动脉瘤的药物中的应用
WO2022223969A1 (en) * 2021-04-20 2022-10-27 Bicycletx Limited Bicyclic peptide ligands specific for p-selectin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
WO1994005269A1 (en) * 1992-09-08 1994-03-17 Centocor, Inc. Peptide inhibitors of selectin binding
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
JPH10502349A (ja) * 1994-06-29 1998-03-03 テキサス・バイオテクノロジー・コーポレイシヨン インテグリンα▲下4▼β▲下1▼のVCAM−1またはフィブロネクチンへの結合を阻害する方法
US5663144A (en) * 1995-05-03 1997-09-02 The Trustees Of The University Of Pennsylvania Compounds that bind to p185 and methods of using the same
US6114517A (en) * 1998-12-10 2000-09-05 Isis Pharmaceuticals Inc. Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
US20020152495A1 (en) * 1999-01-15 2002-10-17 Toshiro Ito Plants having seedless fruit

Also Published As

Publication number Publication date
JP2005501544A (ja) 2005-01-20
CA2459230C (en) 2011-11-08
HRP20040127A2 (en) 2004-06-30
CN1549824A (zh) 2004-11-24
US20050004035A1 (en) 2005-01-06
HUP0401728A2 (hu) 2004-11-29
CN100413883C (zh) 2008-08-27
EP1423413A1 (en) 2004-06-02
ES2337663T3 (es) 2010-04-28
MXPA04002055A (es) 2004-07-08
ATE446311T1 (de) 2009-11-15
ZA200400956B (en) 2005-04-18
EP1288222A1 (en) 2003-03-05
EP1423413B1 (en) 2009-10-21
JP4227520B2 (ja) 2009-02-18
BR0212219A (pt) 2004-09-21
DE60234108D1 (en) 2009-12-03
CA2459230A1 (en) 2003-03-13
PL369030A1 (en) 2005-04-18
US7531516B2 (en) 2009-05-12
WO2003020753A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
WO2002044215A3 (en) Hybrid antibodies
WO2008043822A3 (en) Amino acid sequences that bind to a desired molecule in a conditional manner
WO2003070760A3 (en) Anti-amyloid beta antibodies and their use
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
NO20040905L (no) Peptidaktige forbindelser som selektivt binder til P-selektin, farmasoytiske preparater som inneholder peptidforbindelsene og nukleinsyrer som koder for dem.
WO2002059306A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
BRPI0411766A (pt) métodos para formar uma ligação de dissulfeto e para modificar quimicamente uma proteìna, um peptìdeo ou um aminoácido, composto, método para preparar o composto, uso do composto, e, proteìna, peptìdeo ou aminoácido
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
WO2001081413A3 (en) Isolated human transporter proteins, nucleic acids and uses thereof
WO2001081412A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
WO2002072831A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002022678A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002077190A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002081654A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002033086A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002024748A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002020757A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002064628A3 (en) Isolated human transporter proteins nucleic acids and use thereof
WO2003070882A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
WO2002083731A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002079227A8 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002079432A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002083900A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002079225A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002081657A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application